{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:40:59Z","timestamp":1768891259752,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ucl.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,10,4]],"date-time":"2016-10-04T19:12:58Z","timestamp":1475608378000},"page":"469-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multimodal Therapy in the Management of Advanced Penile Cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Praful","family":"Ravi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance C.","family":"Pagliaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ucl.2016.06.008_bib1","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.ucl.2016.06.008_bib2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1158\/1055-9965.EPI-07-0221","article-title":"Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003","volume":"16","author":"Goodman","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5 Pt 2","key":"10.1016\/j.ucl.2016.06.008_bib3","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.1993.tb16273.x","article-title":"Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis","volume":"72","author":"Ravi","year":"1993","journal-title":"Br J Urol"},{"issue":"19","key":"10.1016\/j.ucl.2016.06.008_bib4","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.ucl.2016.06.008_bib5","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ucl.2016.06.008_bib6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0360-3016(00)00762-8","article-title":"Preoperative chemo-radiation for carcinoma of the vulva with N2\/N3 nodes: a gynecologic oncology group study","volume":"48","author":"Montana","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ucl.2016.06.008_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000030403","article-title":"Issues in the treatment of penile carcinoma. A short review","volume":"62","author":"Hakenberg","year":"1999","journal-title":"Urol Int"},{"issue":"1","key":"10.1016\/j.ucl.2016.06.008_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000480874","article-title":"Up-to-date management of carcinoma of the penis","volume":"32","author":"Pizzocaro","year":"1997","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2016.06.008_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.eururo.2008.04.016","article-title":"Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients","volume":"54","author":"Leijte","year":"2008","journal-title":"Eur Urol"},{"issue":"2\u00a0Suppl 1","key":"10.1016\/j.ucl.2016.06.008_bib10","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2016.06.008_bib11","first-page":"1138","article-title":"Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer","volume":"165","author":"Slaton","year":"2001","journal-title":"J\u00a0Urol"},{"issue":"11","key":"10.1016\/j.ucl.2016.06.008_bib12","doi-asserted-by":"crossref","first-page":"496.e17-23","DOI":"10.1016\/j.urolonc.2015.05.008","article-title":"Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study","volume":"33","author":"Sharma","year":"2015","journal-title":"Urol Oncol"},{"issue":"6b","key":"10.1016\/j.ucl.2016.06.008_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02841868809094366","article-title":"Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis","volume":"27","author":"Pizzocaro","year":"1988","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2016.06.008_bib14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2016.06.008_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/0974-7796.102659","article-title":"Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer","volume":"4","author":"Noronha","year":"2012","journal-title":"Urol Ann"},{"key":"10.1016\/j.ucl.2016.06.008_bib16","article-title":"A\u00a0combination of Cisplatin and 5-Fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings","author":"Nicolai","year":"2015","journal-title":"Clin Genitourin Cancer"},{"issue":"Suppl 2S","key":"10.1016\/j.ucl.2016.06.008_bib17","article-title":"Prognostic factors of adjuvant chemotherapy with taxane, cisplatin, and 5FU combination (TPF) in patients (pts) with nodal metastases of penile squamous cell carcinoma (PSCC)","volume":"34","author":"Necchi","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.ucl.2016.06.008_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jso.20414","article-title":"Prognostic factors in node-positive carcinoma of the penis","volume":"93","author":"Pandey","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"issue":"3","key":"10.1016\/j.ucl.2016.06.008_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncpuro0751","article-title":"Prognostic factors in squamous cell carcinoma of the penis","volume":"4","author":"Novara","year":"2007","journal-title":"Nat Clin Pract Urol"},{"issue":"6","key":"10.1016\/j.ucl.2016.06.008_bib20","first-page":"1823","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study","volume":"161","author":"Haas","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.ucl.2016.06.008_bib21","first-page":"488","article-title":"Neoadjuvant chemotherapy in advanced penile carcinoma","volume":"52","author":"Leijte","year":"2007","journal-title":"Eur\u00a0Urol"},{"issue":"7","key":"10.1016\/j.ucl.2016.06.008_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A\u00a0phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol"},{"issue":"24","key":"10.1016\/j.ucl.2016.06.008_bib23","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","article-title":"Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study","volume":"28","author":"Pagliaro","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.ucl.2016.06.008_bib24","first-page":"1638","article-title":"Contemporary morbidity from lymphadenectomy for penile squamous cell carcinoma: the M.D. Anderson Cancer Center Experience","volume":"167","author":"Bevan-Thomas","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ucl.2016.06.008_bib25","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/bju.12946","article-title":"Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy","volume":"117","author":"Dickstein","year":"2016","journal-title":"BJU Int"},{"issue":"10","key":"10.1016\/j.ucl.2016.06.008_bib26","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1038\/bjc.2013.620","article-title":"Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001)","volume":"109","author":"Nicholson","year":"2013","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2016.06.008_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","article-title":"Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer","volume":"13","author":"Djajadiningrat","year":"2015","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.ucl.2016.06.008_bib28","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","article-title":"EAU guidelines on penile cancer: 2014 update","volume":"67","author":"Hakenberg","year":"2015","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.ucl.2016.06.008_bib29","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.ucl.2016.06.008_bib30","first-page":"17","article-title":"Penile carcinoma: lessons learned from vulvar carcinoma","volume":"189","author":"Longpre","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"5","key":"10.1016\/j.ucl.2016.06.008_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1464-410X.1994.tb09199.x","article-title":"Role of radiation therapy in the treatment of carcinoma of the penis","volume":"74","author":"Ravi","year":"1994","journal-title":"Br J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2016.06.008_bib32","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.clgc.2014.03.009","article-title":"Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma","volume":"12","author":"Pond","year":"2014","journal-title":"Clin Genitourin Cancer"},{"issue":"2","key":"10.1016\/j.ucl.2016.06.008_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1470-2045(12)70570-3","article-title":"International rare cancers initiative","volume":"14","author":"Keat","year":"2013","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.ucl.2016.06.008_bib34","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bju.12563","article-title":"Clinical trial strategy for penis cancer","volume":"113","author":"Nicholson","year":"2014","journal-title":"BJU Int"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014316300271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014316300271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:31:18Z","timestamp":1758807078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014316300271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0094014316300271"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2016.06.008","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal Therapy in the Management of Advanced Penile Cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}